Loading...
 

ARCHIVE

Pneumon 2020, 33(2):1-4
COVID-19 associated Aspergillosis
Authors Information

1Internist – Intensivist, Consultant, Department of Emergency Medicine,
2Professor Critical Care Medicine
Department of Critical Care Medicine, University Hospital ATTIKON, Athens, Greece

Abstract

Invasive pulmonary aspergillosis (IPA) may complicate severe COVID-19 patients. The incidence, although is not well confirmed, varies (20-35%) and the already recognized host factors for IPA in immunosuppressed patients are not identified in non-immunocompromised patients with COVID-19 associated pulmonary aspergillosis (CAPA). Additionally, clinical characteristics and radiological findings are not specific. Given the probable high burden of the co-infection, a screening diagnostic work-up, including serum and BAL galactomannan measurement, fungal cultures of upper and lower respiratory tract samples are considered mandatory in all mechanically ventilated patients with COVID-19.

Pneumon 2020, 33(2):1-4.